A study by UNC Lineberger Comprehensive Cancer Center researchers led by Andrew Wang, MD, has been published in the journal Biomaterials. The study found that a nanoparticle formulation of histone deacetylase inhibitors is more effective in sensitizing solid tumor cells to radiation than small-molecule formations of the drug.
